{"meta":{"query_hash":"9dd8e08505f8","filters":{"venue":"Pharmaceuticals Policy and Law"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9dd8e08505f8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceuticals+Policy+and+Law"},"results":[{"id":"W110544772","doi":"10.3233/ppl-2005-00086","title":"Patent term extension strategies in the pharmaceutical industry","year":2005,"lang":"en","type":"article","venue":"Pharmaceuticals Policy and Law","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmaceutical industry; Business; Yield (engineering); Term (time); Drug prices; Industrial organization; Convention; Orphan drug; Variety (cybernetics); Marketing; International trade; Public economics; Economics; Biotechnology; Law; Computer science; Political science","score_opus":0.3131955677070746,"score_gpt":0.37015339850266177,"score_spread":0.056957830795587194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W110544772","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086865716,0.021667866,0.050144747,0.032453824,0.00039018117,0.0003427166,0.000060244707,0.00029280633,0.8077819],"genre_scores_gemma":[0.9048599,0.009766947,0.016932968,0.0068449117,0.0007399462,0.00032559526,0.000059712398,0.00007341718,0.06039656],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98823464,0.0033558786,0.00079262734,0.0013236953,0.00432991,0.0019632773],"domain_scores_gemma":[0.9814542,0.010811284,0.0027871118,0.0014568048,0.0025740347,0.00091646827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014405362,0.0006018936,0.00053374143,0.003910603,0.0052043814,0.016059536,0.0019763627,0.009041723,0.008307886],"category_scores_gemma":[0.025232665,0.0005871128,0.0009825897,0.0026301937,0.0065751197,0.01571485,0.0060211867,0.0053974283,0.0015751303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027573948,0.00004934634,0.0005048308,0.000052674382,0.0000064159944,0.00031933995,0.0010589013,0.001037054,0.0009809337,0.9585007,0.0033132934,0.034148984],"study_design_scores_gemma":[0.000084331754,0.00044839867,0.0023702346,0.0007861631,0.000064786436,0.0011274548,0.002151534,0.005918135,0.0044608824,0.58721,0.39521745,0.0001606302],"about_ca_topic_score_codex":0.0032756857,"about_ca_topic_score_gemma":0.002408364,"teacher_disagreement_score":0.016059536,"about_ca_system_score_codex":0.007512792,"about_ca_system_score_gemma":0.007821418,"threshold_uncertainty_score":0.07618374},"labels":[],"label_agreement":null},{"id":"W127626386","doi":"10.3233/ppl-2011-0329","title":"Patient involvement in HTA: What added value?","year":2011,"lang":"en","type":"article","venue":"Pharmaceuticals Policy and Law","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international","keywords":"Value (mathematics); Medicine; Intensive care medicine; Mathematics; Statistics","score_opus":0.5504595739640517,"score_gpt":0.4861656519170061,"score_spread":0.06429392204704554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W127626386","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02059173,0.035564367,0.0026454437,0.90384185,0.003937649,0.00022393755,0.00032088984,0.000045367553,0.032828737],"genre_scores_gemma":[0.7941624,0.041769397,0.0067156446,0.140758,0.0116299875,0.00071994594,0.00036909492,0.00009438719,0.0037810532],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.84479046,0.12795834,0.0052887616,0.0021480804,0.015533597,0.004280756],"domain_scores_gemma":[0.64398503,0.28734624,0.016470578,0.008775418,0.020388752,0.023033941],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08962646,0.00075682765,0.0018764758,0.0025146143,0.0023600871,0.018108843,0.0026009814,0.011954986,0.021477975],"category_scores_gemma":[0.32843608,0.0006049705,0.0020680036,0.003309875,0.0111397,0.026090704,0.00976334,0.009095719,0.0017778372],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013254411,0.00082066364,0.03600593,0.0092015555,0.0010210158,0.0015541484,0.0143591175,0.0008875173,0.00022503988,0.10675731,0.10095302,0.72688925],"study_design_scores_gemma":[0.0011629062,0.002303497,0.029296368,0.05527752,0.0016942713,0.00749119,0.07126061,0.0026421386,0.0014166821,0.3950016,0.43195888,0.00049438863],"about_ca_topic_score_codex":0.0022989418,"about_ca_topic_score_gemma":0.0030234766,"teacher_disagreement_score":0.91037357,"about_ca_system_score_codex":0.0076249293,"about_ca_system_score_gemma":0.016830878,"threshold_uncertainty_score":0.4739957},"labels":[],"label_agreement":null},{"id":"W2605059126","doi":"10.3233/ppl-170451","title":"The prevention and detection of corruption in pharmaceutical companies","year":2017,"lang":"en","type":"article","venue":"Pharmaceuticals Policy and Law","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Language change; Business; Risk analysis (engineering); Philosophy","score_opus":0.46350307202145713,"score_gpt":0.6029216068821095,"score_spread":0.13941853486065237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605059126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83388615,0.0063642124,0.02922265,0.022497747,0.00017362944,0.00044522271,0.00014614846,0.00014638784,0.107117735],"genre_scores_gemma":[0.99319094,0.0012527552,0.003311416,0.0006900586,0.000062047046,0.000025731808,0.000038265505,0.0000050455274,0.001423768],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878757,0.005659393,0.000564746,0.0005412897,0.003951139,0.001407687],"domain_scores_gemma":[0.95935845,0.0125942,0.020782927,0.0019509273,0.004392468,0.00092102564],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009474156,0.00017023236,0.00026394802,0.0046402337,0.002451655,0.0033771212,0.0006959795,0.0012808809,0.0011580862],"category_scores_gemma":[0.03089872,0.0002464407,0.00027831047,0.0021959427,0.0030710483,0.0026313637,0.0024961992,0.0018619151,0.00023060871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017291724,0.00045634893,0.4883192,0.00051031995,0.00009061956,0.0019003663,0.0158536,0.0029757828,0.0028732147,0.11754873,0.010577637,0.35872126],"study_design_scores_gemma":[0.00009264882,0.0008360148,0.73446876,0.0026850875,0.0002019052,0.0046530585,0.026751654,0.029612074,0.019789109,0.05699045,0.12368159,0.00023770811],"about_ca_topic_score_codex":0.004111944,"about_ca_topic_score_gemma":0.0045157284,"teacher_disagreement_score":0.9987191,"about_ca_system_score_codex":0.0027986346,"about_ca_system_score_gemma":0.0031518196,"threshold_uncertainty_score":0.050104737},"labels":[],"label_agreement":null}]}